Understanding Apheresis & INUSpheresis

                   Physician-led education on blood filtration, the differences between techniques, and the importance of evidence-based medical indications.

INUSpheresis is not currently offered at AlyneMD. This page provides educational information; a consultation does not reserve an INUSpheresis treatment.

Immune and Vascular Health

A Scientific, Targeted Approach to Blood Filtration
Apheresis is a group of procedures that separate or remove selected blood components. Different methods have different indications, evidence and risks. INUSpheresis is discussed here for education and is not currently offered at AlyneMD. During a consultation, we can review your concerns and discuss available care or an appropriate specialist referral.

Educational Overview

Inuspheresis:
Selective Immune &Inflammatory Filtration

INUSpheresis uses double-filtration plasmapheresis to separate and filter plasma before returning it to the patient. It is not interchangeable with every form of apheresis. Published evidence for broad wellness or longevity benefits remains limited, and potential benefits must be considered alongside procedure-specific risks.

Inuspheresis: Selective Immune &Inflammatory Filtration
Key Points

INUSpheresis — What to Understand

Changes in circulating substances do not, by themselves, establish a lasting health benefit. Treatment decisions require an indication-specific assessment.

Reduces inflammatory cytokines linked to aging and chronic disease
Helps lower Lp(a) and oxidized LDL for select cardiovascular profiles.
Removes autoantibodies and immune complexes.
No donor plasma or albumin replacement required.
Performed under direct physician supervision.
Inuspheresis: Selective Immune &Inflammatory Filtration
Key Highlights

Treatment Highlights and What to Expect

Essential Points
best outcomes
Best outcomes:
Individualized series based
on clinical goals
icon
Procedure time:
60–180 minutes (varies by modality)
icon
Duration of results:
Weeks to months
back to work icon
Back to work:
Same day–24 hrs
recovery icon
Recovery:
Minimal; possible fatigue
icon
Anaesthetic:
Not required
Clinical Improvements

See the Benefits in Action

Lp(a) Improvement

Reduction shown in selected patients undergoing structured protocols.

Inflammatory Markers

Documented improvements in CRP, IL-6, and oxidative markers in appropriate cases.

Symptom Progress

Many patients report improved clarity, stamina, and recovery over time.
What to Expect During Your Visit

What to Expect From Your Treatment Journey

Pre-Treatment

Your physician will review your medical history, labs, & medications to determine the appropriate therapy. Hydration and baseline testing may be required before your session.

Post-Treatment

Mild fatigue or lightheadedness may occur as your system rebalances. Most patients resume normal activities the same day. Follow-up labs & guidance will be provided.

EBOO, INUSpheresis, and Therapeutic Plasma Exchange: How They Differ

These procedures differ in their mechanisms, indications, evidence and risks. Comparing them does not mean they are interchangeable or available at the same clinic. INUSpheresis is not currently offered at AlyneMD; this page is educational.

Swipe to compare
 EBOOINUSpheresisPlasma Exchange (TPE)
What it isExtracorporeal blood oxygenation and ozonationDouble filtration plasmapheresis, also called cascade filtrationFull plasma removal and replacement
Core actionAdds. Blood passes a gas exchange filter where it meets a medical oxygen and ozone mixture, then returns to youFilters. Plasma is separated from your cells, passed through a second size selective filter, and your own plasma is returnedReplaces. Your plasma is removed and substituted with albumin, donor plasma, or a combination
What it addressesOxidative signaling and microcirculation. The circuit filter also captures some lipid and particulate debrisLarger circulating molecules including inflammatory cytokines, immune complexes, autoantibodies, oxidized lipids, and fibrinogenPlasma broadly, including pathogenic antibodies, along with beneficial components such as clotting factors and immunoglobulins
SelectivityNot a removal therapy. Primary effect is oxidative signalingSelective. Sieves by molecular size and retains albumin and smaller beneficial proteinsNon selective. Removes plasma without distinguishing helpful from harmful
Replacement fluidNoneUsually none. Your own filtered plasma is returnedRequired. Albumin and or donor plasma
Typical sessionAbout 45 to 60 minutesAbout 2 to 3 hoursAbout 2 to 4 hours
AccessTwo IV sites, typically one per armTwo IV sitesTwo large bore IV sites, or central access in some cases
Typical courseUsually a series, spaced per physician planOften an initial session or two, then reassessment with labsA defined series determined by indication
Often chosen forOxidative stress, inflammation, circulation, energy and recovery goalsA measurable inflammatory or environmental burden identified on testingEstablished autoimmune and neurologic indications
Status to understandOzone therapy is not FDA approved for the treatment of disease in the United States and is offered at physician discretionNot FDA cleared for use in the United States. Established in European clinical practice, where published studies to date are limited in number and largely observationalThe most established of the three, recognized in American Society for Apheresis guidelines for specific conditions

The short version

EBOO is the shortest and lightest touch, focused on oxidative and circulatory support rather than removal. INUSpheresis is the selective one, built to take out specific large molecules while giving your own plasma back. TPE is the most established and the most aggressive, removing plasma wholesale and replacing it, which is why it is reserved for defined medical indications and requires replacement fluid.

None of these is a better therapy in the abstract. They answer different questions. Your candidacy assessment starts with what your testing shows, not with the technology.

Read more about EBOO therapy at AlyneMD

What the evidence shows

It helps to separate the technique from the specific system. Double filtration plasmapheresis, the method INUSpheresis uses, was introduced in the early 1980s and has been used since then in immune mediated, hematological, and neurological conditions. The mechanism is well characterized and the technique itself is long established.

The published work on the INUSpheresis system specifically is more recent and much smaller in scale. It consists largely of retrospective series and case reports rather than randomized controlled trials. Two recent European analyses examined how efficiently the system separates plasma and which circulating substances it captures, across a few dozen procedures in small patient groups.

This information is provided to support an informed discussion, not as an offer of INUSpheresis treatment. Dr. Sandhu can review your concerns and discuss available care or specialist evaluation. Read our physician review of INUSpheresis evidence and U.S. availability →

Selected references: Castillo-Aleman et al., Journal of Clinical Apheresis, 2025. Castillo-Aleman et al., Therapeutic Apheresis and Dialysis, 2026. Double filtration plasmapheresis was first described by Agishi et al. in the early 1980s.

Read our physician guide to INUSpheresis evidence and U.S. availability →

Why Choose AlyneMD

Physician AlyneMD
Physician-Led Care

Treatment plans are set by a physician after an examination.

Selected Technology

Devices and injectables are chosen for the specific concern, with their FDA status explained before treatment.

Individual Plans

Each plan reflects your examination, medical history and goals.

Frequently Asked Questions

How is Inuspheresis different from blood detox?

INUSpheresis is a form of plasma filtration, not a general-purpose detox treatment. The procedure, its risks and the evidence for a particular indication should be evaluated separately.

Is this safe?

Extracorporeal blood procedures are not risk-free. Medical screening, vascular access, anticoagulation and monitoring require specialist assessment. Risks vary by method and patient. INUSpheresis is not currently offered at AlyneMD.

How do I know which therapy I need?

A consultation begins with your symptoms, medical history and relevant testing. We discuss available care and specialist referral when appropriate. INUSpheresis is not currently an AlyneMD treatment option; ask Dr. Sandhu about longevity options during a consultation.

How many sessions will I need?

Session count varies based on your goals and medical profile.

Can this be combined with peptides or hormone optimization?

Yes—many patients combine these therapies with peptide and metabolic protocols.

Do you offer plasma exchange on-site?

Plasma exchange is offered selectively and may be completed at a partner facility when advanced monitoring is needed.

What is the difference between EBOO and INUSpheresis?

EBOO exposes your blood to a medical oxygen and ozone mixture to support oxidative signaling and microcirculation, and takes about 45 to 60 minutes. INUSpheresis is a filtration therapy that separates your plasma and passes it through a size selective filter to remove larger molecules such as inflammatory cytokines and oxidized lipids, then returns your own plasma. It takes about 2 to 3 hours. EBOO adds. INUSpheresis removes.

Is INUSpheresis the same as therapeutic plasma exchange?

No. Therapeutic plasma exchange removes your plasma entirely and replaces it with albumin or donor plasma. INUSpheresis filters your plasma and gives it back, so replacement fluid is usually not needed. That difference is why the two have different risk profiles and different indications.

How do I know which blood therapy is right for me?

Your medical history, symptoms and relevant testing guide the discussion. A consultation may lead to available treatment, further evaluation or specialist referral. It does not establish candidacy for every therapy discussed on this page; INUSpheresis is not currently offered at AlyneMD.

Where can I have INUSpheresis performed near New York City?

INUSpheresis is not currently offered at AlyneMD in Warren or New York. This page is educational. Call 908-888-9199 to discuss the services we offer; please do not book expecting an INUSpheresis procedure.

PERSONALIZED CONSULTATION

The right treatment starts with candidacy.

We evaluate anatomy, medical history, expectations, and treatment alternatives before recommending a procedure.

ASSESS YOUR CANDIDACY→
CLINICAL JUDGMENTBEFORE INTERVENTION